|
| Status |
Public on Sep 18, 2024 |
| Title |
Syndecan-1 inhibition promotes anti-tumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
39259785 |
| |
| Submission date |
Apr 30, 2023 |
| Last update date |
Sep 19, 2024 |
| Contact name |
Yun Liu |
| E-mail(s) |
liuyun29@shsci.org
|
| Organization name |
Shanghai Cancer Institute
|
| Street address |
No. 2200, Xietu Road, Xuhui District, Shanghai, China
|
| City |
Shanghai |
| ZIP/Postal code |
200000 |
| Country |
China |
| |
|
| Platforms (2) |
| GPL17021 |
Illumina HiSeq 2500 (Mus musculus) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
| Samples (14)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE231355 |
Syndecan-1 inhibition promotes anti-tumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy [kdSdc1_RNAseq] |
| GSE231356 |
Syndecan-1 inhibition promotes anti-tumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy [kdSdc1_scRNAseq] |
|
| Relations |
| BioProject |
PRJNA964463 |
Less...
More...